Document is current

Jensen, Laura J. http://orcid.org/0000-0002-6436-5733

Rogasch, Julian M. M. http://orcid.org/0000-0002-0817-6532

Kim, Damon http://orcid.org/0000-0003-3145-7559

Rießelmann, Juliana

Furth, Christian http://orcid.org/0000-0001-7302-7886

Amthauer, Holger http://orcid.org/0000-0003-4414-0657

Hamm, Bernd http://orcid.org/0000-0002-9141-027X

Steffen, Ingo G. http://orcid.org/0000-0003-2059-4275

Elgeti, Thomas http://orcid.org/0000-0002-7155-6044

Nagel, Sebastian N. http://orcid.org/0000-0002-9489-2913

Funding for this research was provided by:

Actelion Pharmaceuticals

Bayer Schering

Bayer Vital

Bristol-Myers Squibb

Charité Research Organisation GmbH

Abbot

BRACCO Group

Deutsche Krebshilfe

Essex Pharma

Guerbet

INC Research

InSightec Ud

IPSEN Pharma

Kendlel MorphoSys AG

Lilly GmbH

MeVis Medical Solutions AG

Nexus Oncology

Novartis

Parexel Clinical Research Organisation Service

Pfizer GmbH

Philipps

Sanofis-Aventis

Siemens

Teruma Medical Corporation

Toshiba

Zukunfsfond Berlin

Amgen

AO Foundation

BARD

BBraun

Boehring Ingelheimer

Brainsgate

CELLACT Pharma

CeloNova Bio-Sciences

North Carolina GlaxoSmithKline Foundation

Jansen

Roehe

Sehumaeher GmbH

Medtronic

Pluristem

Quintiles

Astellas

Chiltern

Respicardia

TEVA

Abbvie

AstraZeneca

Galmed Research and Development

Charité - Universitätsmedizin Berlin

Text and Data Mining valid from 2022-11-21

Version of Record valid from 2022-11-21